Red Nucleus, a life sciences services company, has acquired Bridge Medical Consulting, a health economics and outcomes research consultancy. Red Nucleus has been majority owned by THL since 2024 and is expanding its value and evidence platform through add-on acquisitions.Founded in 2011 by Paul Gandhi, Bridge Medical Consulting provides evidence synthesis, integrated evidence planning, health economic modeling, statistics, and real-world evidence used by pharmaceutical and biotechnology customer...
Continue Reading
Sign up for FREE to read the full article and access 129K+ alternative investment headlines.